1 out of 4 CBD Products is NOT Tested

for Microbial Content, Pesticides, or Heavy Metals 

The CBD industry’s peer-reviewed watchdog Leafreport.com recently undertook an comprehensive review of 2946 products from 136 brands to verify how many were being tested by third-party facilities for purity or potency. The report also released a list of the top ten most transparent brands.

“The CBD industry is still very unregulated,” said Shafir, the head of product at Leafreport. “There have been many cases of companies selling products that contain little to no CBD–that’s why third-party testing is so critical for brands in this industry.”

Pure, Clean CBD? It’s Unlikely: Only 13% of Brands Tested Almost All of Their Products for Purity

‘Clean’, ‘safe’, ‘natural’, or ‘pure’ CBD are pivotal selling points for many CBD brands. However, these buzz words are meaningless without the evidence to support such claims.

One of the key findings of the report was that only 13% of CBD companies tested almost all of their products for detectable levels of contaminants such as heavy metals, pesticides, or microbial content. But 25% didn’t test any of their products for purity at all.

“We were stunned to find that of the big-name brands we reviewed, one in four didn’t test any of their products for the presence of contaminants,” said Shafir. “It’s particularly concerning given that hemp, from which CBD is extracted, is a phyto-remedial plant that absorbs toxins and heavy metals from the soil”.

Do Most CBD Products Deliver the Promised Potency? Don’t Bet on It–84% Don’t Measure within the Acceptable Variance

Among other key findings exposed by the report were significant discrepancies between the product’s labelled potency compared with the contents of the bottle.

The concentration of CBD stated on a product label must match the concentration measured by the testing laboratory within a 10% variance, which means that a high-quality CBD product is expected to have CBD levels that are within 90–110% of what is advertised.

84% of the 2946 products tested were found to be outside the limits of acceptable variance. Leafreport also uncovered that only 42% of brands tested all their products for potency.

“The number of brands sidestepping third-party potency testing, or testing outside the allowable variance, is a genuine source of concern,” commented Shafir.

“Testing to ensure the potency of your product is accurate is a fundamental aspect of brand integrity–especially in the case of CBD products that are frequently used as medicine. Children diagnosed with rare forms of pediatric epilepsy use CBD to help control seizures, so it’s absolutely essential that their caregivers know what’s in the bottle to get dosage right.”

Less is More: Brands with Fewer than 8 Products are More Likely to Test for Both Purity and Potency

Another telling finding revealed by the report was that brands offering 7 products or less were more likely to test most of their products for both potency and purity, as opposed to brands with over 40 products. These results suggest that third-party testing may be more manageable, and financially practicable, for brands with fewer products.

It’s Time for CBD Brands to Level Up and Become More Accountable

Overall, the findings of the report indicate that vast discrepancies and unknowns characterize what consumers believe they are purchasing–and the actual contents of the CBD product.

“The excitement generated by CBD has led to the explosion of largely unregulated industry that must become more accountable to consumers,” reflected Shafir.

Transparency report summary

 

http://d1h.7b5.myftpupload.com/industry-insights/1-out-of-4-cbd-products-is-not-tested/?fbclid=IwAR0ih9_—UVMaK3xssQ6gXX17GwuP4fDbbXSRKDVZMz0krJ7UKUkkIpUf4

 

 

Recent Articles

You’ve chosen to work in a gray area. You sell products that contain cannabis or cannabis-adjacent substances as well as accessories that can be used to consume it. And while that area has become less gray—you can see rays of sunlight peeking through—the skies are still cloudy. THC remains a Schedule 1 substance, even as medical marijuana has migrated to Schedule 3.
Running a cannabis business is notoriously complicated. For dispensaries, complex compliance burdens permeate every facet of the business, from zoning and licensing to marketing and payments. Whether you’ve been in the cannabis space for mere months or multiple decades, you’ve likely run into drawn-out approval processes, supply chain headaches, or constantly changing regulation that makes compliance challenging, not to mention the other micro and macroeconomic factors that plague all small business owners.
Blending traditional values with modernized, energetic branding, Not Ya Son’s Weed falls somewhere between the cannabis days of yore and today’s recreational cannabis boom. Not Ya Son’s Weed offers a variety of products—including pre-rolls, exotic flower, and gummies—that provide much-needed relief without being too overbearing.
The officials came for Lance Alyas once before. In 2023, they caught him in a sting, seized his merchandise, and tossed him in jail. But just seven days later, after he invoked Hawaii's version of a Freedom of Information Act request, the whole case fell apart. Alyas was released without bail, allowed to simply walk out the door. Now, he’s advocating for freedom from Hawaii’s state officials once again. Only this time, it’s not just his own freedom. As the owner of Oahu’s top-rated smoke shops, he’s fighting for everyone’s right to sell hemp products in the Aloha State.
Born Sara Benetowa in Warsaw, Poland, in 1903, Sula Benet may not be an immediately recognizable name in cannabis spaces today, but she should be. While she primarily studied Polish folk customs, Benet became known for her graduate thesis at the University of Warsaw, titled Hashish in Folk Customs and Beliefs. In the paper, she claims that the plant kaneh bosm—which is referenced throughout the Old Testament and Torah and often translated as “calamus”—actually refers to hemp. Benet’s theory remains both significant and highly controversial today, especially as various religious and evangelical groups continue to demonize the plant.
If the United States were ever a country based on strict adherence to the law, those days are long past. The modern game lies in devising methods to circumvent laws. It’s how the rich avoid taxes, the powerful avoid jail, and industries of all kinds bypass regulations. The paradox is that, despite its ubiquity, it’s not easy to stay beyond the reach of the long arm of the law. Well-moneyed, influential organizations still sometimes misjudge the political and legal playing field and have to pay up. The Sacklers (the family behind Purdue Pharma) eventually were bankrupted by the courts for their role in the opioid epidemic, and officials hit Meta with a $5 billion fine over privacy concerns.
When you walk into a smoke shop today, you might notice the glass cases that once held rolling papers and blunt wraps now display CBD tinctures, functional mushroom capsules, kava elixirs, and hemp-infused sparkling water. The staff might talk to you about terpene profiles, cortisol levels, and a new vape line.
I went home and told my girlfriend, who, after Googling the name of the business I bought it from, told me that, yes, it was technically weed. But it was CBD. She started laughing, telling me I had been ripped off.